The development and validation of the treatment of autoimmune bullous disease quality of life questionnaire, a tool to measure the quality of life impacts of treatments used in patients with autoimmune blistering disease.

Abstract

BACKGROUND Treatments for autoimmune blistering diseases have significant risk of medical complications and quality of life impacts during treatment, and it is difficult to differentiate these impacts from disease burden or the effects of treatment. OBJECTIVES To develop a quality of life instrument specific to the effects of treatments used in patients… (More)
DOI: 10.1111/bjd.12623

Topics

Cite this paper

@article{Tjokrowidjaja2013TheDA, title={The development and validation of the treatment of autoimmune bullous disease quality of life questionnaire, a tool to measure the quality of life impacts of treatments used in patients with autoimmune blistering disease.}, author={Angelina Tjokrowidjaja and Benjamin S. Daniel and John W Frew and Deshan F Sebaratnam and A. M. Hanna and Seongtaek Chee and Agus Dermawan and C. Q. Wang and C. Lim and Sharmila Venugopal and Lowrey Rhodes and Brian T Welsh and T Nijsten and D F Murrell}, journal={The British journal of dermatology}, year={2013}, volume={169 5}, pages={1000-6} }